GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Dr. Lal PathLabs Ltd (BOM:539524) » Definitions » Cyclically Adjusted Book per Share

Dr. Lal PathLabs (BOM:539524) Cyclically Adjusted Book per Share : ₹167.98 (As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is Dr. Lal PathLabs Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Dr. Lal PathLabs's adjusted book value per share for the three months ended in Mar. 2025 was ₹260.619. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₹167.98 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Dr. Lal PathLabs's average Cyclically Adjusted Book Growth Rate was 20.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2025-05-20), Dr. Lal PathLabs's current stock price is ₹2795.20. Dr. Lal PathLabs's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was ₹167.98. Dr. Lal PathLabs's Cyclically Adjusted PB Ratio of today is 16.64.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Dr. Lal PathLabs was 22.13. The lowest was 14.99. And the median was 19.23.


Dr. Lal PathLabs Cyclically Adjusted Book per Share Historical Data

The historical data trend for Dr. Lal PathLabs's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr. Lal PathLabs Cyclically Adjusted Book per Share Chart

Dr. Lal PathLabs Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 139.27 167.98

Dr. Lal PathLabs Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 139.27 - 158.65 - 167.98

Competitive Comparison of Dr. Lal PathLabs's Cyclically Adjusted Book per Share

For the Diagnostics & Research subindustry, Dr. Lal PathLabs's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dr. Lal PathLabs's Cyclically Adjusted PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Dr. Lal PathLabs's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Dr. Lal PathLabs's Cyclically Adjusted PB Ratio falls into.


;
;

Dr. Lal PathLabs Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Dr. Lal PathLabs's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book= Book Value per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=260.619/157.5517*157.5517
=260.619

Current CPI (Mar. 2025) = 157.5517.

Dr. Lal PathLabs Quarterly Data

Book Value per Share CPI Adj_Book
201506 0.000 99.841 0.000
201509 49.504 101.753 76.650
201512 0.000 102.901 0.000
201603 56.432 102.518 86.726
201606 0.000 105.961 0.000
201609 72.506 105.961 107.808
201612 0.000 105.196 0.000
201703 71.692 105.196 107.373
201706 0.000 107.109 0.000
201709 81.840 109.021 118.271
201712 0.000 109.404 0.000
201803 94.542 109.786 135.675
201806 0.000 111.317 0.000
201809 104.881 115.142 143.511
201812 0.000 115.142 0.000
201903 113.448 118.202 151.215
201906 0.000 120.880 0.000
201909 126.971 123.175 162.407
201912 0.000 126.235 0.000
202003 123.920 124.705 156.560
202006 0.000 127.000 0.000
202009 138.761 130.118 168.017
202012 0.000 130.889 0.000
202103 149.386 131.771 178.614
202106 0.000 134.084 0.000
202109 164.533 135.847 190.821
202112 0.000 138.161 0.000
202203 182.219 138.822 206.804
202206 0.000 142.347 0.000
202209 187.014 144.661 203.679
202212 0.000 145.763 0.000
202303 200.902 146.865 215.521
202306 0.000 150.280 0.000
202309 213.194 151.492 221.722
202312 0.000 152.924 0.000
202403 222.235 153.035 228.795
202406 0.000 155.789 0.000
202409 240.300 157.882 239.797
202412 0.000 158.323 0.000
202503 260.619 157.552 260.619

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Dr. Lal PathLabs  (BOM:539524) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Dr. Lal PathLabs's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=2795.20/167.98
=16.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Dr. Lal PathLabs was 22.13. The lowest was 14.99. And the median was 19.23.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Dr. Lal PathLabs Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Dr. Lal PathLabs's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Dr. Lal PathLabs Business Description

Traded in Other Exchanges
Address
12th Floor, Tower B, SAS Tower, Sector 38, Medicity, Gurugram, HR, IND, 122 001
Dr. Lal PathLabs Ltd is a pathology lab based in India. It is involved in providing diagnostic services and other healthcare tests in the area of pathology and radiology. The company operates laboratories for carrying out pathological diagnostic services in various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, and other pathological and radiological investigations. Its diagnostic services assist to prevent, monitor and treat diseases and improving health conditions. The company has business operations in India and other countries, of which maximum revenue is generated within India.

Dr. Lal PathLabs Headlines

No Headlines